BioSig Technologies, Inc. (BSGM)
| Market Cap | 106.17M |
| Revenue (ttm) | 325,000 |
| Net Income (ttm) | -37.72M |
| Shares Out | 34.92M |
| EPS (ttm) | -1.21 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,946 |
| Open | - |
| Previous Close | 3.03 |
| Day's Range | 2.83 - 3.04 |
| 52-Week Range | 2.67 - 6.14 |
| Beta | 1.75 |
| Analysts | Buy |
| Price Target | 13.00 (+329.0%) |
| Est. Earnings Date | Nov 4, 2021 |
About BSGM
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial...
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for BSGM stock is "Buy" and the 12-month stock price forecast is 13.00.
News
BioSig's PURE EP Aims to Address Unmet Needs of Afib Patients
Image by PublicDomainPictures from Pixabay An estimated 33.5 million individuals worldwide and nearly 2.7 million people in the U.S. live with an often silent, untreated medical issue.
BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors
James J. Barry, Ph.D. will join as an Independent Director as Company expands clinical footprint with its signal processing technology for arrhythmia care James J. Barry, Ph.D. will join as an Independe...
BioSig Expands in Electrophysiology with St. Elizabeth's Medical Center Evaluation
Increasing its ever-growing presence in the cardiac electrophysiology space, BioSig Technologies (NASDAQ: BSGM) will be installing one of its new PURE EP systems in St. Elizabeth's Medical Center in Bos...
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overa...
BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Sy...
Physician-only event, organized by the University of Pennsylvania, is a tribute to the pioneer of cardiac electrophysiology Physician-only event, organized by the University of Pennsylvania, is a tribut...
BioSig's Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium
A physician user from a leading medical center of excellence will present the technology and discuss recent clinical data A physician user from a leading medical center of excellence will present the te...
BioSig To Host Presentations from Physician Users of its Signal Processing System for Arrhythmia Care during the annu...
Confirmed speakers include the largest technology users from Mayo Clinic, Texas Cardiac Arrhythmia Institute, and University of Pennsylvania Confirmed speakers include the largest technology users from ...
BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology
Texas installation builds as company adds team members to support installations around major metropolitan areas Texas installation builds as company adds team members to support installations around maj...
BioSig to Host Conference Call to Unblind Clinical Data Collected with its Signal Processing Technology for Arrhythmi...
Westport, CT, July 12, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platfo...
BioSig Announces Closing of Public Offering of Common Stock
Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal process...
BioSig Enters the New York Market with Its Signal Processing Technology for Electrophysiology
The Company installs its novel medical technology platform for arrhythmia care in a leading Center of Excellence The Company installs its novel medical technology platform for arrhythmia care in a leadi...
Mayo Clinic Purchases BioSig's PURE EP™ for use at its Phoenix Location
According to a recently filed 8-k, BioSig Technologies, Inc. (NASDAQ: BSGM) received a new purchase order from the Mayo Foundation for medical education and research. The institution commenced the evalu...
BioSig Technologies Raises $10M Via Equity Issued At $4/Share
BioSig Technologies Inc (NASDAQ: BSGM) has priced its previously announced underwritten public offering of 2.5 million shares at $4.00 per share, representing a discount of 8% from the last close price ...
BioSig Announces Pricing of Public Offering of Common Stock
Westport, CT, July 02, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal process...
BioSig Announces Proposed Public Offering of Common Stock
Westport, CT, July 01, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal proce...
BioSig Completes 1,000 Patient Cases and Expects 1,500 more at the end of 2021
According to recent reports, the global electroceuticals/bioelectric medicine market is currently worth $16.8 billion and is projected to reach $21.5 billion by 2026, at a compound annual growth rate (C...
BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology
Westport, CT, June 30, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal proces...
BioSig's Signal Processing Technology for Electrophysiology To Be Featured During 2021 Stanford Biodesign New Arrhyth...
Presentation to highlight clinical applications of the Company's latest software for arrhythmia care Presentation to highlight clinical applications of the Company's latest software for arrhythmia care
BioSig's Signal Processing System for Electrophysiology Featured in Two Clinical and Scientific Presentations during ...
Abstracts are due to be presented by physician users and research investigators from two leading institutions Abstracts are due to be presented by physician users and research investigators from two lea...
BioSig Technologies, Inc. to Present at the LD Micro Invitational XI Virtual Event
Presentation on Tuesday, June 8, 2021, at 5 PM ET Presentation on Tuesday, June 8, 2021, at 5 PM ET
BioSig Technologies, Inc. to Present at the Jefferies Virtual Healthcare Conference
Westport, CT, May 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform...
BioSig Technologies, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit
Westport, CT, May 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform...
BioSig Technologies looking to unlock the future of bioelectronic medicine
Using targeted electrical signals to harness the body's natural mechanisms to diagnose and treat a range of diseases Has commercialized its first product, a biomedical signal processing platform called ...
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians have conducted over 800 arrhythmia patient cases t...